Trial intelligence / Profile preview

Early Treatment vs Expectant Management of PDA in Preterm Infants

NCT03860428Completed

Sponsor
Danylo Halytsky Lviv National Medical University
Start
Feb 2019
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (3 arms), sponsored by Danylo Halytsky Lviv National Medical University. Primary endpoint: Incidence of bronchopulmonary dysplasia (BPD) or mortality. Started Feb 2019; status: completed.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on NCT03860428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03860428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call